z-logo
open-access-imgOpen Access
Advantages of long-term combination pharmacotherapy with a beta-blocker and eplerenone in patients with ST-segment elevation acute coronary syndrome
Author(s) -
О. А. Осипова,
В. П. Михин,
Andrey I. Golovin,
О Б Белоусова,
D. N. Perutsky,
П. К. Алферов,
С. Л. Константинов
Publication year - 2022
Publication title -
kardiovaskulârnaâ terapiâ i profilaktika
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.158
H-Index - 16
eISSN - 2619-0125
pISSN - 1728-8800
DOI - 10.15829/1728-8800-2022-3269
Subject(s) - medicine , cardiology , nebivolol , ejection fraction , eplerenone , heart failure , acute coronary syndrome , percutaneous coronary intervention , diastole , spironolactone , myocardial infarction , blood pressure

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here